Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
19.11
-0.31 (-1.60%)
Mar 28, 2025, 3:00 PM CST
SHA:601607 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Operating Revenue | 275,251 | 259,152 | 231,240 | 215,824 | 191,423 | Upgrade
|
Other Revenue | - | 1,143 | 741.24 | - | 485.96 | Upgrade
|
Revenue | 275,251 | 260,295 | 231,981 | 215,824 | 191,909 | Upgrade
|
Revenue Growth (YoY) | 5.75% | 12.21% | 7.49% | 12.46% | 2.86% | Upgrade
|
Cost of Revenue | 244,619 | 229,366 | 201,604 | 187,416 | 165,671 | Upgrade
|
Gross Profit | 30,632 | 30,929 | 30,377 | 28,408 | 26,238 | Upgrade
|
Selling, General & Admin | 18,404 | 19,527 | 19,173 | 18,376 | 16,797 | Upgrade
|
Research & Development | 2,394 | 2,204 | 2,112 | 1,987 | 1,657 | Upgrade
|
Other Operating Expenses | 143.51 | 376.86 | 654.72 | 633.18 | 587.25 | Upgrade
|
Operating Expenses | 20,942 | 22,349 | 22,214 | 20,942 | 18,956 | Upgrade
|
Operating Income | 9,690 | 8,581 | 8,164 | 7,466 | 7,282 | Upgrade
|
Interest Expense | - | -1,885 | -1,689 | -1,518 | -1,412 | Upgrade
|
Interest & Investment Income | 380.43 | 461.83 | 971.41 | 2,150 | 1,265 | Upgrade
|
Currency Exchange Gain (Loss) | - | 11.41 | 21.51 | 10.1 | -41.43 | Upgrade
|
Other Non Operating Income (Expenses) | -1,828 | -109.59 | -116.44 | -128.71 | -119.03 | Upgrade
|
EBT Excluding Unusual Items | 8,243 | 7,059 | 7,351 | 7,979 | 6,974 | Upgrade
|
Impairment of Goodwill | - | - | - | -19.21 | -486.27 | Upgrade
|
Gain (Loss) on Sale of Investments | 203.85 | 155.93 | 218.74 | -206 | 116.8 | Upgrade
|
Gain (Loss) on Sale of Assets | 187.97 | 92.48 | 1,439 | 58.29 | 52.15 | Upgrade
|
Asset Writedown | -614.37 | -70.65 | -322.79 | -69.77 | -15.77 | Upgrade
|
Legal Settlements | - | -12.69 | -37.38 | -8.1 | -34.82 | Upgrade
|
Other Unusual Items | - | -169.95 | 160.13 | 409.61 | 569.14 | Upgrade
|
Pretax Income | 8,020 | 7,054 | 8,808 | 8,144 | 7,175 | Upgrade
|
Income Tax Expense | 2,150 | 1,888 | 1,816 | 1,869 | 1,570 | Upgrade
|
Earnings From Continuing Operations | 5,870 | 5,167 | 6,992 | 6,275 | 5,605 | Upgrade
|
Minority Interest in Earnings | -1,317 | -1,399 | -1,375 | -1,181 | -1,109 | Upgrade
|
Net Income | 4,553 | 3,768 | 5,617 | 5,093 | 4,496 | Upgrade
|
Net Income to Common | 4,553 | 3,768 | 5,617 | 5,093 | 4,496 | Upgrade
|
Net Income Growth | 20.82% | -32.92% | 10.28% | 13.28% | 10.17% | Upgrade
|
Shares Outstanding (Basic) | 3,701 | 3,701 | 3,483 | 2,842 | 2,842 | Upgrade
|
Shares Outstanding (Diluted) | 3,701 | 3,701 | 3,483 | 2,842 | 2,842 | Upgrade
|
Shares Change (YoY) | -0.00% | 6.28% | 22.54% | - | - | Upgrade
|
EPS (Basic) | 1.23 | 1.02 | 1.61 | 1.79 | 1.58 | Upgrade
|
EPS (Diluted) | 1.23 | 1.02 | 1.61 | 1.79 | 1.58 | Upgrade
|
EPS Growth | 20.82% | -36.77% | -10.06% | 13.29% | 10.04% | Upgrade
|
Free Cash Flow | 3,426 | 2,261 | 2,058 | 942.55 | 3,835 | Upgrade
|
Free Cash Flow Per Share | 0.93 | 0.61 | 0.59 | 0.33 | 1.35 | Upgrade
|
Dividend Per Share | - | 0.410 | 0.610 | 0.420 | 0.480 | Upgrade
|
Dividend Growth | - | -32.79% | 45.24% | -12.50% | 9.09% | Upgrade
|
Gross Margin | 11.13% | 11.88% | 13.10% | 13.16% | 13.67% | Upgrade
|
Operating Margin | 3.52% | 3.30% | 3.52% | 3.46% | 3.79% | Upgrade
|
Profit Margin | 1.65% | 1.45% | 2.42% | 2.36% | 2.34% | Upgrade
|
Free Cash Flow Margin | 1.24% | 0.87% | 0.89% | 0.44% | 2.00% | Upgrade
|
EBITDA | 11,387 | 9,922 | 9,689 | 8,973 | 8,779 | Upgrade
|
EBITDA Margin | 4.14% | 3.81% | 4.18% | 4.16% | 4.57% | Upgrade
|
D&A For EBITDA | 1,698 | 1,341 | 1,526 | 1,507 | 1,496 | Upgrade
|
EBIT | 9,690 | 8,581 | 8,164 | 7,466 | 7,282 | Upgrade
|
EBIT Margin | 3.52% | 3.30% | 3.52% | 3.46% | 3.79% | Upgrade
|
Effective Tax Rate | 26.81% | 26.76% | 20.62% | 22.95% | 21.88% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.